How to use an article about genetic association B: Are the results of the study valid?

JAMA

Volumn 301, Issue 2, 2009, Pages 191-197

  Attia, John ^a,e   Ioannidis, John P A ^b,c   Thakkinstian, Ammarin ^d   McEvoy, Mark ^e   Scott, Rodney J ^a,f   Minelli, Cosetta ^g   Thompson, John ^h   Infante Rivard, Claire ⁱ   Guyatt, Gordon ^j  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF IOANNINA   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f JOHN HUNTER HOSPITAL   (Australia)

^g NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^h UNIVERSITY OF LEICESTER   (United Kingdom)

ⁱ MCGILL UNIVERSITY   (Canada)

^j MCMASTER UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA SEQUENCE; ETHNIC DIFFERENCE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; HUMAN; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; VALIDITY; ARTICLE; GENETIC LINKAGE; INHERITANCE; LITERATURE; MEDICAL GENETICS; PUBLICATION; REPRODUCIBILITY;

GENETIC MARKERS; GENETIC VARIATION; GENETICS, MEDICAL; GENOTYPE; HUMANS; INHERITANCE PATTERNS; LINKAGE (GENETICS); PERIODICALS AS TOPIC; PHENOTYPE; REPRODUCIBILITY OF RESULTS; REVIEW LITERATURE AS TOPIC;

EID: 58249089746     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2008.946     Document Type: Review

References (59)

1. Attia J, Ioannidis JPA, Thakkinstian A, et al. How to use an article about genetic association: A: background concepts. JAMA. 2009;301(1):74-81.
2. Slooter AJ, Cruts M, Hofman A, et al. The impact of APOE on myocardial infarction, stroke, and dementia: the Rotterdam Study. Neurology. 2004;62(7):1196-1198.
3. Ioannidis JP. Contradicted and initially stronger effects in highly cited clinical research. JAMA. 2005;294(2):218-228.
4. Ioannidis JP, Trikalinos TA. Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials. J Clin Epidemiol. 2005;58(6):543-549.
5. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet. 2003;361(9360):865-872.
6. Cordell HJ, Clayton DG. Genetic association studies. Lancet. 2005;366(9491):1121-1131.
7. Hattersley AT, McCarthy MI. What makes a good genetic association study? Lancet. 2005;366(9493):1315-1323.
8. Ioannidis JP, Boffetta P, Little J, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37(1):120-132.
9. Little J, Bradley L, Bray MS, et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol. 2002;156(4):300-310.
10. Laupacis A, Wells G, Richardson WS, Tugwell P; Evidence-Based Medicine Working Group. Users' guides to the medical literature, V: how to use an article about prognosis. JAMA. 1994;272(3):234-237.
11. Randolph A, Cook DJ, Guyatt G. Prognosis. In: Guyatt G, Rennie D, Meade M, Cook D, eds. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. New York, NY: McGraw-Hill; 2008.
12. Levine M, Walter S, Lee H, Haines T, Holbrook A, Moyer V; Evidence-Based Medicine Working Group. Users' guides to the medical literature, IV: how to use an article about harm. JAMA. 1994;271(20):1615-1619.
13. Levine M, Ioannidis J, Haines T, Guyatt G. Harm (observational studies). In: Guyatt G, Rennie D, Meade M, Cook D, eds. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. New York, NY: McGraw-Hill; 2008.
14. Contopoulos-Ioannidis DG, Alexiou GA, Gouvias TC, Ioannidis JP. An empirical evaluation of multifarious outcomes in pharmacogenetics: beta-2 adrenoceptor gene polymorphisms in asthma treatment. Pharmacogenet Genomics. 2006;16(10):705-711.
15. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661-678.
16. Evangelou E, Trikalinos TA, Salanti G, Ioannidis JP. Family-based versus unrelated case-control designs for genetic associations. PLoS Genet. 2006;2(8):e123.
17. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96(6):434-442.
18. Barnholtz-Sloan JS, McEvoy B, Shriver MD, Rebbeck TR. Ancestry estimation and correction for population stratification in molecular epidemiologic association studies. Cancer Epidemiol Biomarkers Prev. 2008;17(3):471-477.
19. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet. 1999;65(1):220-228.
20. Kittles RA, Chen W, Panguluri RK, et al. CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification? Hum Genet. 2002;110(6):553-560.
21. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889-894.
22. Zeggini E, Weedon MN, Lindgren CM, et al; Wellcome Trust Case Control Consortium (WTCCC). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316(5829):1336- 1341.
23. Richards JB, Rivadeneira F, Inouye M, et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet. 2008;371(9623):1505-1512.
24. Clayton DG, Walker NM, Smyth DJ, et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet. 2005;37(11):1243-1246.
25. Akey JM, Zhang K, Xiong M, Doris P, Jin L. The effect that genotyping errors have on the robustness of common linkage-disequilibrium measures. Am J Hum Genet. 2001;68(6):1447-1456.
26. Bogardus ST Jr, Concato J, Feinstein AR. Clinical epidemiological quality in molecular genetic research: the need for methodological standards. JAMA. 1999;281(20):1919-1926.
27. Mein CA, Barratt BJ, Dunn MG, et al. Evaluation of single nucleotide polymorphism typing with invader on PCR amplicons and its automation. Genome Res. 2000;10(3):330-343.
28. Pompanon F, Bonin A, Bellemain E, Taberlet P. Genotyping errors: causes, consequences and solutions. Nat Rev Genet. 2005;6(11):847-859.
29. Slooter AJ, Cruts M, Kalmijn S, et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol. 1998;55(7):964-968.
30. Cox DG, Kraft P. Quantification of the power of Hardy-Weinberg equilibrium testing to detect genotyping error. Hum Hered. 2006;61(1):10-14.
31. Hosking L, Lumsden S, Lewis K, et al. Detection of genotyping errors by Hardy-Weinberg equilibrium testing. Eur J Hum Genet. 2004;12(5):395-399.
32. Leal SM. Detection of genotyping errors and pseudo-SNPs via deviations from Hardy-Weinberg equilibrium. Genet Epidemiol. 2005;29(3):204-214.
33. Montoya-Delgado LE, Irony TZ, de B Pereira CA, Whittle MR. An unconditional exact test for the Hardy-Weinberg equilibrium law: sample-space ordering using the Bayes factor. Genetics. 2001;158(2):875-883.
34. Salanti G, Amountza G, Ntzani EE, Ioannidis JP. Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet. 2005;13(7):840-848.
35. Xu J, Turner A, Little J, Bleecker ER, Meyers DA. Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? Hum Genet. 2002;111(6):573-574.
36. Tufts University Comparative and Molecular Pharmacogenomics Laboratory. A simple calculator to determine whether observed genotype frequencies are consistent with Hardy-Weinberg equilibrium. http://www.tufts.edu/~mcourt01/ Documents/Court%20lab%20-%20HW%20calculator.xls. Accessed October 25, 2008.
37. Freimer N, Sabatti C. The use of pedigree, sibpair and association studies of common diseases for genetic mapping and epidemiology. Nat Genet. 2004;36(10):1045-1051.
38. Ioannidis JP. Calibration of credibility of agnostic genome-wide associations. Am J Med Genet B Neuropsychiatr Genet. 2008. doi:10.1002/ajmg.b.30721.
39. Province MA. Sequential methods of analysis for genome scans. Adv Genet. 2001;42:499-514.
40. Sabatti C. Avoiding false discoveries in association studies. Methods Mol Biol. 2007;376:195-211.
41. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289-300.
42. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat. 2001;29:1165-1188.
43. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. http://jnci.oxfordjournals.org/cgi/content/full/ 96/6/434/DC1?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&author1= wacholder&andorexacttitle=and&andorexacttitleabs=and& andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec= relevance&resourcetype=HWCIT. Accessed October 25, 2008.
44. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001;29(3):306-309.
45. Hoggart CJ, Clark TG, De Iorio M, Whittaker JC, Balding DJ. Genome-wide significance for dense SNP and resequencing data. Genet Epidemiol. 2008;32(2):179-185.
46. McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008;9(5):356-369.
47. Chanock SJ, Manolio T, Boehnke M, et al; NCI-NHGRI Working Group on Replication in Association Studies. Replicating genotype-phenotype associations. Nature. 2007;447(7145):655-660.
48. Ioannidis JP, Trikalinos TA, Khoury MJ. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol. 2006;164(7):609-614.
49. Moonesinghe R, Khoury MJ, Liu T, Ioannidis JP. Required sample size and nonreplicability thresholds for heterogeneous genetic associations. Proc Natl Acad Sci U S A. 2008;105(2):617-622.
50. Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet. 2004;20(9):439-444.
51. Salanti G, Sanderson S, Higgins JP. Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med. 2005;7(1):13-20.
52. Khoury MJ, Dorman JS. The Human Genome Epidemiology Network. Am J Epidemiol. 1998;148(1):1-3.
53. Little J, Higgins J. The HuGENet HuGE Review Handbook. Ottawa, Ontario, Canada: HuGENet Canada; 2008. http://www.hugenet.ca. Accessed October 25, 2008.
54. Human Genome Epidemiology Network. A navigator for human genome epidemiology. http://www.hugenavigator.net/. Accessed October 25, 2008.
55. Yu W, Gwinn M, Clyne M, Yesupriya A, Khoury MJ. A navigator for human genome epidemiology. Nat Genet. 2008;40(2):124-125.
56. Becker KG, Barnes KC, Bright TJ, Wang SA. The genetic association database. Nat Genet. 2004;36(5):431-432.
57. Farrer LA, Cupples LA, Haines JL, et al; for the APOE and Alzheimer Disease Meta Analysis Consortium. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA. 1997;278(16):1349-1356.
58. Rubinsztein DC, Easton DF. Apolipoprotein E genetic variation and Alzheimer's disease: a meta-analysis. Dement Geriatr Cogn Disord. 1999;10(3):199-209.
59. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007;39(1):17-23.